These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 6437432)

  • 1. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
    Wearne A; Joshua DE; Kronenberg H
    Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulation and prognosis in myeloma.
    Joshua DE; Wearne A; Kronenberg H
    Lancet; 1987 Jan; 1(8527):251-3. PubMed ID: 2880070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring circulating B cells in patients with multiple myeloma at diagnosis or in plateau phase: how prevalent is light chain isotype suppression?
    King MA; Radicchi MA
    Br J Haematol; 1992 Jun; 81(2):218-22. PubMed ID: 1379466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature.
    Turesson I; Grubb A
    Acta Med Scand; 1978; 204(6):445-51. PubMed ID: 104550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: human B cells can simultaneously express cell surface kappa and lambda light chains.
    Pauza ME; Rehmann JA; LeBien TW
    J Exp Med; 1993 Jul; 178(1):139-49. PubMed ID: 8391059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
    Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
    Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group.
    Leonard RC; MacLennan IC; Smart Y; Vanhegan RI; Cuzick J
    Int J Cancer; 1979 Oct; 24(4):385-93. PubMed ID: 118938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring myeloma: light chain isotype suppression. A new parameter.
    Wearne A; Joshua DE; Kronenberg H
    Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
    Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
    Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
    Nelson M; Brown RD; Gibson J; Joshua DE
    Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.
    Ioannidis RA; Joshua DE; Warburton PT; Francis SE; Brown RD; Gibson J; Kronenberg H
    Hematol Pathol; 1989; 3(4):169-75. PubMed ID: 2516854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface immunoglobulin light chain expression in pre-B cell leukemias.
    Koziner B; Stavnezer J; Al-Katib A; Gebhard D; Mittelman A; Andreeff M; Clarkson BD
    Ann N Y Acad Sci; 1986; 468():211-26. PubMed ID: 2425686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the usefulness of measuring the serum and urine levels of light chain immunoglobulins in multiple myeloma and Waldenström's macroglobulinemia].
    Kraj M; Maj S; Rostkowska J
    Acta Haematol Pol; 1991; 22(1):21-30. PubMed ID: 1823963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Light chain myeloma or the pitfalls of myeloma diagnosis].
    Zufferey P; Pugin P; Regamey C
    Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphoma.
    Sobol RE; Dillman RO; Collins H; Griffiths JC; Green MR; Royston I
    Cancer; 1985 Oct; 56(8):2005-10. PubMed ID: 3928135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins.
    Bagg A; Becker P; Bezwoda W; van Rensburg L; Mendelow B
    Br J Haematol; 1989 Jun; 72(2):167-72. PubMed ID: 2503024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
    Solomon A; Weiss DT; Macy SD; Antonucci RA
    Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma].
    Iavorskiĭ LI; Andreeva NE; Antipova LG; Riauzova LN
    Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):3-9. PubMed ID: 111238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.